A. Chetta (Parma, Italy), J. Vestbo (Hvidovre, Denmark)
Predictors of body mass index and body fat after lung and heart transplantation
L. Forli, J. Bollerslev, S. Simonsen, G. Isaksen, K. Godang, A. Pripp, O. Bjortuft (Norway)
|  |
Bronchial hyperreactivity (BHR) and loss of FEV1 in treated and untreated sarcoidosis patients
M. Martusewicz-Boros, P. Boros, E. Puscinska, S. Wesolowski, D. Górecka, E. Wiatr, K. Roszkowski-Sliz (Warsaw, Poland)
|  |
A prospective observational trial examining the value of serum procalcitonin in the diagnosis of pleural infection
C. E. Hooper, A. J. Morley, J. Jukes, J. E. Harvey, N. A. Maskell (Bristol, United Kingdom)
| |
Simultaneous oesophageal & tracheal pH monitoring in chest disease
T. Jordan, H. Tan, A. Collins, M. Ledson, M. Walshaw (United Kingdom)
|  |
Osteoporosis and body composition in COPD: The CIROCO study
E. A. P. M. Romme, E. Rutten, M. A. Spruit, F. M. E. Franssen, K. Gunawardena, E. F. M. Wouters (Eindhoven, Horn, Maastricht, Netherlands; Charnwood, United Kingdom)
| |
Clinical decision making in alpha1 antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV1 decline
A. I. Shamji, A. C. Bradi, K. R. Chapman (Toronto, Canada)
| |